Health Care: Drugs

Merrimack Pharmaceuticals Inc (MACK: NASDAQ)

$1.4 n/a | n/a%
06/28/17 - 04:00 PM ET
Latest Dividend:1.0552
Latest Dividend Yield:34.8684%
Dividend Ex-Date:05/30/17
Price Earnings Ratio:n/a
Price Earnings Comparisons:
MACKSector Avg.S&P 500
n/a030.4
Price Performance History (% change):
3 Mo1 Yr3 Yr
-53.4884-74.6835-80.8743
GROWTH12 Mo3 YrCAGR
Revenue61.620.44
Net Income0.20
EPS-0.1n/a
Earnings for MACK:
EBITDA-98.00
REVENUE144.27M
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $-0.14 $-0.14 $-0.54 $-0.65
Number of Analysts 3 2 3 3
High Estimate $-0.02 $-0.08 $-0.44 $-0.55
Low Estimate $-0.21 $-0.19 $-0.62 $-0.71
Prior Year $-0.40 $-0.23 $-1.21 $-0.54
Growth Rate (Year over Year) 65.83% 41.30% 55.65% -20.50%

Portfolios with MACK

Latest MACK Headlines from TheStreet

More Financial News for MACK

Press Releases for MACK

See All Press Releases

Partner Headlines for MACK

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter